Literature DB >> 1738939

HLA in human serum--quantitation of class I by enzyme immunoassay.

J C McDonald1, F B Gelder, D F Aultman, M D Landreneau, R W McMillan, I Singh, D Sorrells, W H Liou.   

Abstract

A solid-phase, enzyme-linked immunoassay was used to quantitate the soluble fraction of HLA-class I. The sera of 318 individuals were studied, as well as the urine of six individuals with normal renal function. The stability of blood concentrations of the soluble HLA was also evaluated. The data justify the following six conclusions. (1) All normal people have circulating HLA (mean = 357 ng/ml). (2) The population can be divided into one group of low secretors (mean = 162.4 +/- 65.2 ng/ml) and another group of high secretors (mean = 540.7 +/- 185.9 ng/ml) (P less than 0.01). (3) Blood levels in each individual are reasonably consistent over short (days) and long (years) periods of time. (4) The mean concentration of soluble HLA-class I in all renal failure patients was 590 ng/ml, significantly higher than normal (P = less than 0.05); it was highest in patients on peritoneal dialysis (mean = 683 ng/ml) in spite of substantial chronic loss in peritoneal dialysate. (5) Renal allograft recipients with stable allograft function also had mean values greater than normal at 554 ng/ml (P less than 0.05). (6) Soluble HLA-class I was not detected in the urine of individuals with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738939     DOI: 10.1097/00007890-199202010-00034

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Authors:  Irena Adamashvili; Roger E Kelley; Thomas Pressly; John C McDonald
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

Review 2.  Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.

Authors:  Katerina Bakela; Irene Athanassakis
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

Review 3.  In search of the Holy Grail (actively acquired immunologic tolerance).

Authors:  J C McDonald
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

4.  Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease.

Authors:  C Moore; M Ehlayel; J Inostroza; L E Leiva; S Kuvibidila; L Yu; R Gardner; D L Ode; R Warrier; R U Sorensen
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

5.  Soluble HLA class I in the serum of transplant recipients.

Authors:  V K Rhynes; J C McDonald; F B Gelder; D F Aultman; J M Hayes; R W McMillan; M C Mancini
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.

Authors:  Irena Adamashvili; Robert Wolf; Donnie Aultman; Edgar L Milford; Stephen Jaffe; Vicky Hall; Thomas Pressly; Alireza Minagar; Roger Kelley
Journal:  Rheumatol Int       Date:  2003-07-23       Impact factor: 2.631

7.  Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.

Authors:  Irena Adamashvili; Alireza Minagar; Eduardo Gonzalez-Toledo; Liubov Featherston; Roger E Kelley
Journal:  J Neuroinflammation       Date:  2005-06-02       Impact factor: 8.322

8.  Serum and urine soluble HLA class I antigen concentrations are increased in patients with hemorrhagic fever with renal syndrome.

Authors:  C W Park; S N Yun; C W Yang; T G Kim; H Han; E J Choi; Y S Chang; B K Bang
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

9.  Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum.

Authors:  Dong Il Won; Nan Young Lee; Jeong-Hoon Lim; Young Seok Han; Chan-Duck Kim; Seung Huh
Journal:  Blood Res       Date:  2020-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.